These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25745990)

  • 1. Rationale and design of RETAIN study: Rosuvastatin Effect on Telomere-telomerase system in Acute coronary syndrome patients undergoing percutaneous coronary Intervention.
    Zhuang XD; Liao LZ; Guo Y; Li Y; Liao XX; Hu X; Du ZM
    Int J Cardiol; 2015 Apr; 184():388-390. PubMed ID: 25745990
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention.
    Guo J; Zhang WZ; Zhao Q; Wo JS; Cai SL
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4457-4463. PubMed ID: 29077146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials.
    Pan Y; Tan Y; Li B; Li X
    Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia.
    Canepa M; Artom N; Ameri P; Carbone F; Montecucco F; Ghigliotti G; Brunelli C; Dallegri F; Pende A; Pisciotta L
    Int J Cardiol; 2018 Mar; 255():215-220. PubMed ID: 29290422
    [No Abstract]   [Full Text] [Related]  

  • 7. [IMPACT OF ATORVASTATIN AND ROSUVASTATIN ON RESIDUAL ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS AFTER ACUTE CORONARY SYNDROME].
    Ovrakh T; Serik S; Kochubiei O
    Georgian Med News; 2017 Apr; (265):7-14. PubMed ID: 28574378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
    Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
    Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).
    Otagiri K; Tsutsui H; Kumazaki S; Miyashita Y; Aizawa K; Koshikawa M; Kasai H; Izawa A; Tomita T; Koyama J; Ikeda U
    Circ J; 2011; 75(3):633-41. PubMed ID: 21266787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.
    Ray KK; Nicholls SJ; Ginsberg HD; Johansson JO; Kalantar-Zadeh K; Kulikowski E; Toth PP; Wong N; Cummings JL; Sweeney M; Schwartz GG
    Am Heart J; 2019 Nov; 217():72-83. PubMed ID: 31520897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI.
    Sun C; Zheng W; Liang L; Liu Z; Sun W; Tang R
    J Interv Cardiol; 2021; 2021():2995602. PubMed ID: 34566523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.
    Luo J; Li J; Shen X; Hu X; Fang Z; Lv X; Zhou S
    Int J Cardiol; 2013 Sep; 167(5):2350-3. PubMed ID: 23194788
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
    Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Lenzen MJ; Simsek C; de Boer SP; Van Mieghem NM; Regar E; de Jaegere PP; Akkerhuis KM; Ligthart JM; Zijlstra F; Serruys PW; Boersma E
    EuroIntervention; 2016 Aug; 12(6):734-9. PubMed ID: 27542785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins.
    Altaf A; Qu P; Zhao Y; Wang H; Lou D; Niu N
    Coron Artery Dis; 2015 Aug; 26(5):409-21. PubMed ID: 25946654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
    Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
    Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
    Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
    Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome.
    Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y
    Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.